![Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities | Nature Reviews Rheumatology Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41584-021-00657-4/MediaObjects/41584_2021_657_Fig1_HTML.png)
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities | Nature Reviews Rheumatology
![Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis - ScienceDirect Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049017221001839-ga1.jpg)
Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis - ScienceDirect
![Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension | Hypertension Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension | Hypertension](https://www.ahajournals.org/cms/asset/aade3d38-3dd8-44e7-83c0-72e65c8d125f/1102fig01.jpeg)
Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension | Hypertension
![Pharmaceuticals | Free Full-Text | Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat | HTML Pharmaceuticals | Free Full-Text | Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-11-00051/article_deploy/html/images/pharmaceuticals-11-00051-g001.png)
Pharmaceuticals | Free Full-Text | Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat | HTML
![Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review - Clinical Therapeutics Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b20b9a36-3c6b-46da-abea-3b75bf7418cf/gr4_lrg.jpg)